SARS-CoV-2疫苗的国家内年龄优先、全球分配与公共卫生影响的数学建模分析
研究扩展SARS-CoV-2传播数学模型,评估不同国家环境下疫苗的公共卫生影响。发现疫苗影响取决于接种时累积感染率、自然免疫持续时间、疫情轨迹和医疗可及性;有限供应下国内优先老年人,供应增加后转向关键传播者;全球按人口比例分配剂量接近最优且符合伦理原则。
要点
- 有限供应(<20%人口剂量)时国内最优策略为优先老年人。
- 供应增加且维持其他干预时,最优策略转向关键传播者以间接保护脆弱人群。
- 全球按人口比例分配2021年20亿剂接近最优减少死亡。
核心结论
- SARS-CoV-2疫苗接种的公共卫生影响取决于接种时累积感染率、自然免疫持续时间、疫情轨迹和医疗可及性。
- 国内有限供应时优先老年人;供应增加且维持其他干预时转向关键传播者以间接保护脆弱人群。
- 全球按人口比例分配2021年20亿剂接近最优减少死亡,符合大流行防范规划伦理原则。
研究设计与样本
- 扩展SARS-CoV-2跨国家传播数学模型,使用WHO目标产品特性评估疫苗影响。
- 识别在剂量供应约束下最大化减少死亡的国家内和国家间最优分配策略。
主要发现
- 有限供应(<20%人口剂量)时国内最优策略为优先老年人。
- 供应增加且维持其他干预时,最优策略转向关键传播者以间接保护脆弱人群。
- 供应增加时,减少或阻断感染的疫苗比仅预防疾病的疫苗影响更大,因对高风险群体提供间接保护。
- 2021年全球20亿剂按人口比例分配接近最优减少死亡。
关键数值与推荐
- 有限供应定义为剂量覆盖<20%人口。
- 2021年全球剂量供应为20亿剂。
- 按人口比例分配策略接近最优减少死亡。
临床怎么用
- 有限供应阶段国内优先老年人以减少死亡。
- 供应增加且维持其他干预时,转向关键传播者以间接保护脆弱人群。
- 全球分配按人口比例接近最优且符合伦理原则。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The worldwide endeavour to develop safe and effective COVID-19 vaccines has been extraordinary, and vaccination is now underway in many countries. However, the doses available in 2021 are likely to be limited. We extend a mathematical model of SARS-CoV-2 transmission across different country settings to evaluate the public health impact of potential vaccines using WHO-developed target product profiles. We identify optimal vaccine allocation strategies within- and between-countries to maximise averted deaths under constraints on dose supply. We find that the health impact of SARS-CoV-2 vaccination depends on the cumulative population-level infection incidence when vaccination begins, the duration of natural immunity, the trajectory of the epidemic prior to vaccination, and the level of healthcare available to effectively treat those with disease. Within a country we find that for a limited supply (doses for < 20% of the population) the optimal strategy is to target the elderly. However, with a larger supply, if vaccination can occur while other interventions are maintained, the optimal strategy switches to targeting key transmitters to indirectly protect the vulnerable. As supply increases, vaccines that reduce or block infection have a greater impact than those that prevent disease alone due to the indirect protection provided to high-risk groups. Given a 2 billion global dose supply in 2021, we find that a strategy in which doses are allocated to countries proportional to population size is close to optimal in averting deaths and aligns with the ethical principles agreed in pandemic preparedness planning.
引用
- Hogan AB, Winskill P, Watson OJ, et al. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis. Vaccine. 2021. PMID: 33933313. doi:10.1016/j.vaccine.2021.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。